Correlation Between Cannara Biotech and Elixxer

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Elixxer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Elixxer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and Elixxer, you can compare the effects of market volatilities on Cannara Biotech and Elixxer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Elixxer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Elixxer.

Diversification Opportunities for Cannara Biotech and Elixxer

0.0

Correlation Coefficient

Cannara Biotech  Elixxer

Pay attention - limited upside

The 3 months correlation between Cannara and Elixxer is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Elixxer in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elixxer and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Elixxer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elixxer has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Elixxer go up and down completely randomly.

Pair Corralation between Cannara Biotech and Elixxer

If you would invest  61.00  in Cannara Biotech on September 30, 2024 and sell it today you would earn a total of  17.00  from holding Cannara Biotech or generate 27.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cannara Biotech  vs.  Elixxer

Cannara Biotech

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Elixxer

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Elixxer has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Elixxer is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Cannara Biotech and Elixxer

The main advantage of trading using opposite Cannara Biotech and Elixxer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Elixxer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elixxer will offset losses from the drop in Elixxer's long position.

The idea behind Cannara Biotech and Elixxer pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.